{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:35:56Z","timestamp":1707525356114},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,3]]},"DOI":"10.7759\/cureus.46401","type":"journal-article","created":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T11:04:23Z","timestamp":1696331063000},"source":"Crossref","is-referenced-by-count":0,"title":["Ceftriaxone-Related Encephalopathy in a Patient With End-Stage Renal Disease and High Ceftriaxone Concentrations in Cerebrospinal Fluid and Plasma: A Case Report"],"prefix":"10.7759","author":[{"given":"Tomonori","family":"Takano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Kaburagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Morikubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002455","article-title":"Antibiotic-associated encephalopathy","volume":"86","author":"Bhattacharyya S","year":"2016","unstructured":"Bhattacharyya S, Darby RR, Raibagkar P, Gonzalez Castro LN, Berkowitz AL. Antibiotic-associated encephalopathy. Neurology. 2016, 86:963-71. 10.1212\/WNL.0000000000002455","journal-title":"Neurology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.01.023","article-title":"Ceftriaxone-associated encephalopathy in a patient with high levels of ceftriaxone in blood and cerebrospinal fluid","volume":"116","author":"Nishioka H","year":"2022","unstructured":"Nishioka H, Cho Y, Irie K, Kanamori M. Ceftriaxone-associated encephalopathy in a patient with high levels of ceftriaxone in blood and cerebrospinal fluid. Int J Infect Dis. 2022, 116:223-5. 10.1016\/j.ijid.2022.01.023","journal-title":"Int J Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A0655","article-title":"MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings","volume":"28","author":"Kim E","year":"2007","unstructured":"Kim E, Na DG, Kim EY, Kim JH, Son KR, Chang KH. MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings. AJNR Am J Neuroradiol. 2007, 28:1652-8. 10.3174\/ajnr.A0655","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref4","article-title":"Drug dosing adjustments in patients with chronic kidney disease","volume":"75","author":"MUNAR MY","year":"2007","unstructured":"MUNAR MY, SINGH H. Drug dosing adjustments in patients with chronic kidney disease. Am Fam Phys. 2007, 75:1487-96.","journal-title":"Am Fam Phys"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.1785-18","article-title":"Encephalopathy induced by high plasma and cerebrospinal fluid ceftriaxone concentrations in a hemodialysis patient","volume":"58","author":"Suzuki S","year":"2019","unstructured":"Suzuki S, Naito S, Numasawa Y, et al.. Encephalopathy induced by high plasma and cerebrospinal fluid ceftriaxone concentrations in a hemodialysis patient. Intern Med. 2019, 58:1775-9. 10.2169\/internalmedicine.1785-18","journal-title":"Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2017.03.009","article-title":"Three cases of hemodialysis patients receiving high-dose ceftriaxone: serum concentrations and its neurotoxicity","volume":"2","author":"Inoue Y","year":"2017","unstructured":"Inoue Y, Doi Y, Arisato T, Sugioka S, Koga K, Nishioka K, Sugawara A. Three cases of hemodialysis patients receiving high-dose ceftriaxone: serum concentrations and its neurotoxicity. Kidney Int Rep. 2017, 2:984-7. 10.1016\/j.ekir.2017.03.009","journal-title":"Kidney Int Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/108185","article-title":"Ceftriaxone-induced acute encephalopathy in a peritoneal dialysis patient","volume":"2014","author":"Safadi S","year":"2014","unstructured":"Safadi S, Mao M, Dillon JJ. Ceftriaxone-induced acute encephalopathy in a peritoneal dialysis patient. Case Rep Nephrol. 2014, 2014:108185. 10.1155\/2014\/108185","journal-title":"Case Rep Nephrol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/hdi.13018","article-title":"Two cases of ceftriaxone-induced encephalopathy treated by hemoperfusion in hemodialysis patients","volume":"26","author":"Onogi C","year":"2022","unstructured":"Onogi C, Osada A, Imai K, et al.. Two cases of ceftriaxone-induced encephalopathy treated by hemoperfusion in hemodialysis patients. Hemodial Int. 2022, 26:E27-30. 10.1111\/hdi.13018","journal-title":"Hemodial Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00874-20","article-title":"Population pharmacokinetic study of ceftriaxone in elderly patients, using cystatin C-based estimates of renal function to account for frailty","volume":"64","author":"Tan SJ","year":"2020","unstructured":"Tan SJ, Cockcroft M, Page-Sharp M, et al.. Population pharmacokinetic study of ceftriaxone in elderly patients, using cystatin C-based estimates of renal function to account for frailty. Antimicrob Agents Chemother. 2020, 64:10.1128\/AAC.00874-20","journal-title":"Antimicrob Agents Chemother"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2005.08.005","article-title":"Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children","volume":"26","author":"Goldwater PN","year":"2005","unstructured":"Goldwater PN. Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children. Int J Antimicrob Agents. 2005, 26:408-11. 10.1016\/j.ijantimicag.2005.08.005","journal-title":"Int J Antimicrob Agents"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections","volume":"23","author":"Nau R","year":"2010","unstructured":"Nau R, S\u00f6rgel F, Eiffert H. Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev. 2010, 23:858-83. 10.1128\/CMR.00007-10","journal-title":"Clin Microbiol Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/47.4.421","article-title":"The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients","volume":"47","author":"Joynt GM","year":"2001","unstructured":"Joynt GM, Lipman J, Gomersall CD, Young RJ, Wong EL, Gin T. The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients. J Antimicrob Chemother. 2001, 47:421-9. 10.1093\/jac\/47.4.421","journal-title":"J Antimicrob Chemother"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkad190","article-title":"Validating a novel three-times-weekly post-hemodialysis ceftriaxone regimen in infected Indigenous Australian patients-a population pharmacokinetic study","volume":"78","author":"Tsai D","year":"2023","unstructured":"Tsai D, Zam BB, Tongs C, et al.. Validating a novel three-times-weekly post-hemodialysis ceftriaxone regimen in infected Indigenous Australian patients-a population pharmacokinetic study. J Antimicrob Chemother. 2023, 78:1963-73. 10.1093\/jac\/dkad190","journal-title":"J Antimicrob Chemother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2009.06.008","article-title":"Pharmacokinetics and pharmacodynamics of antibacterial agents","volume":"23","author":"Levison ME","year":"2009","unstructured":"Levison ME, Levison JH. Pharmacokinetics and pharmacodynamics of antibacterial agents. Infect Dis Clin North Am. 2009, 23:791-815, vii. 10.1016\/j.idc.2009.06.008","journal-title":"Infect Dis Clin North Am"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/187822-ceftriaxone-related-encephalopathy-in-a-patient-with-end-stage-renal-disease-and-high-ceftriaxone-concentrations-in-cerebrospinal-fluid-and-plasma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:07:47Z","timestamp":1707509267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/187822-ceftriaxone-related-encephalopathy-in-a-patient-with-end-stage-renal-disease-and-high-ceftriaxone-concentrations-in-cerebrospinal-fluid-and-plasma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,3]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.46401","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,3]]}}}